Susanna Mierau, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microelectrodes | 1 | 2024 | 306 | 0.870 |
Why?
|
| Organoids | 3 | 2024 | 744 | 0.840 |
Why?
|
| Nutritional Support | 1 | 2019 | 173 | 0.580 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2016 | 894 | 0.520 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2015 | 182 | 0.440 |
Why?
|
| Pyramidal Cells | 1 | 2015 | 366 | 0.410 |
Why?
|
| Nutritional Status | 1 | 2019 | 1597 | 0.370 |
Why?
|
| Neurons | 5 | 2024 | 9429 | 0.360 |
Why?
|
| Interneurons | 1 | 2015 | 587 | 0.350 |
Why?
|
| Visual Cortex | 1 | 2015 | 1104 | 0.280 |
Why?
|
| Somatosensory Cortex | 2 | 2009 | 512 | 0.240 |
Why?
|
| Action Potentials | 3 | 2024 | 1830 | 0.210 |
Why?
|
| Protein Subunits | 2 | 2016 | 940 | 0.200 |
Why?
|
| Frontotemporal Dementia | 1 | 2021 | 245 | 0.150 |
Why?
|
| Synaptic Transmission | 1 | 2004 | 1167 | 0.150 |
Why?
|
| Tissue Culture Techniques | 1 | 2019 | 289 | 0.150 |
Why?
|
| Nerve Net | 2 | 2024 | 2288 | 0.140 |
Why?
|
| Diet, Gluten-Free | 1 | 2019 | 283 | 0.140 |
Why?
|
| Neuronal Plasticity | 2 | 2019 | 1432 | 0.130 |
Why?
|
| Astrocytes | 2 | 2021 | 1341 | 0.130 |
Why?
|
| Neurotransmitter Agents | 1 | 2019 | 664 | 0.120 |
Why?
|
| Parvalbumins | 1 | 2015 | 260 | 0.110 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 680 | 0.100 |
Why?
|
| Membrane Potentials | 1 | 2015 | 1088 | 0.100 |
Why?
|
| Vitamins | 1 | 2019 | 1634 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2021 | 1462 | 0.090 |
Why?
|
| Pyrazines | 1 | 2016 | 1202 | 0.090 |
Why?
|
| Actinomycetales | 1 | 2009 | 33 | 0.080 |
Why?
|
| Actinomycetales Infections | 1 | 2009 | 30 | 0.080 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2009 | 59 | 0.080 |
Why?
|
| Long-Term Potentiation | 1 | 2009 | 290 | 0.070 |
Why?
|
| Mice | 4 | 2024 | 81330 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2019 | 3410 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2016 | 1977 | 0.060 |
Why?
|
| Pneumonia, Bacterial | 1 | 2009 | 316 | 0.060 |
Why?
|
| Synapses | 1 | 2015 | 1755 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 22128 | 0.060 |
Why?
|
| Animals | 6 | 2024 | 168089 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 5775 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 924 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14392 | 0.040 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2019 | 174 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 792 | 0.040 |
Why?
|
| Brain | 1 | 2024 | 27094 | 0.040 |
Why?
|
| Presynaptic Terminals | 1 | 2019 | 302 | 0.040 |
Why?
|
| Behavior | 1 | 2019 | 540 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2016 | 109 | 0.030 |
Why?
|
| Species Specificity | 1 | 2019 | 2406 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2016 | 369 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 2016 | 335 | 0.030 |
Why?
|
| Xenopus | 1 | 2016 | 709 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 2016 | 428 | 0.030 |
Why?
|
| Humans | 7 | 2024 | 761222 | 0.030 |
Why?
|
| Glycine | 1 | 2016 | 659 | 0.030 |
Why?
|
| Pluripotent Stem Cells | 1 | 2019 | 794 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2019 | 1769 | 0.020 |
Why?
|
| Dogs | 1 | 2016 | 3832 | 0.020 |
Why?
|
| Axons | 1 | 2019 | 1671 | 0.020 |
Why?
|
| Oocytes | 1 | 2016 | 1165 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 3057 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2019 | 1545 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1085 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2019 | 1492 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2016 | 1173 | 0.020 |
Why?
|
| Learning | 1 | 2019 | 1737 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 1852 | 0.020 |
Why?
|
| Cell Survival | 1 | 2019 | 5778 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2019 | 3056 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2813 | 0.020 |
Why?
|
| Male | 4 | 2019 | 360703 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2009 | 469 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 8164 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2019 | 6635 | 0.010 |
Why?
|
| Female | 3 | 2019 | 392552 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 4413 | 0.010 |
Why?
|
| Calcium | 1 | 2016 | 5719 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 18927 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 39957 | 0.010 |
Why?
|
| Stroke | 1 | 2019 | 9721 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 23419 | 0.010 |
Why?
|
| Aged | 1 | 2009 | 169292 | 0.000 |
Why?
|